1992
DOI: 10.1007/bf00714176
|View full text |Cite
|
Sign up to set email alerts
|

Functional dynamic MRI, pharmacokinetics and safety of Gd-DTPA in patients with impaired renal function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0
1

Year Published

1993
1993
2007
2007

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 44 publications
(19 citation statements)
references
References 13 publications
0
18
0
1
Order By: Relevance
“…In patients with a clearance below 30 ml/min, no signal decrease is seen anymore indicating the loss of the concentration ability of the kidney (Fig. 7) [13].…”
Section: Renal Insufficiencymentioning
confidence: 97%
See 1 more Smart Citation
“…In patients with a clearance below 30 ml/min, no signal decrease is seen anymore indicating the loss of the concentration ability of the kidney (Fig. 7) [13].…”
Section: Renal Insufficiencymentioning
confidence: 97%
“…In contrast to iodinated contrast agents as used in CT, administration of gadolinium compounds is not contraindicated in patients with impaired renal function [13,39]. Therefore, dynamic contrast-enhanced MRI may be performed even in patients with bilateral renal insufficiency.…”
Section: Renal Insufficiencymentioning
confidence: 98%
“…In patients with renal parenchymal diseases dynamic functional studies may be performed using a GRE sequence with simultaneous T1-and T2-influence (GRASS, FFE, FLASH without spoiling gradients). Rapid repetition of 16±32 single scans in the same position with TR = 30 ms, TE = 16 ms, flip angle = 70 using a reduced (190 256) matrix allows a reduction in acquisition times to 5±6 s/slice, which are followed by breathing periods of 4±5 s resulting in a temporal resolution of 10 s. Gd-DTPA or Gd-DOTA are administered after the first scan as a bolus in a concentration of 0.1 mmol/kg body weight [10]. 7.…”
Section: Mr Imaging Strategiesmentioning
confidence: 99%
“…Only when the contrast agent passes into the calyces and is diluted with non-contrasted glomerular filtrate does the SI increase again to approximately equal values as in the cortex. Excretion into the calyces usually may be demonstrated at this point: It is characterized by a SI decrease in the region of the renal pelvis, which is also followed by susceptibility artifacts [1,2,10,11].…”
Section: Normal Morphology and Function Of The Kidneys And Adrenal Glmentioning
confidence: 99%
“…The procedure is noninvasive and the gadolinium-based contrast agents used in 3D-Gd-MRA are not nephrotoxic when the correct dosage is used (2,8,9). The clinical value of 3D-Gd-MRA is now well documented (10 -14).…”
mentioning
confidence: 99%